Paclitaxel and carboplatin plus megestrol acetate in the treatment of advanced non-small cell lung cancerTHONGPRASERT, Sumitra; EUATHRONGCHIT, Juntima; CHEEWAKRIANGKRAI, Rattiya et al.Chot Mai Het Thang Phaet. 2002, Vol 85, Num 4, pp 424-432, issn 0125-2208, 9 p.Article

Docetaxel as second-line chemotherapy for advanced non-small cell lung cancerTHONGPRASERT, Sumitra; CHEEWAKRIANGKRAI, Rattiya; NAPAPAN, Sirikul et al.Chot Mai Het Thang Phaet. 2002, Vol 85, Num 12, pp 1296-1300, issn 0125-2208, 5 p.Article

Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: A multicenter studyTHONGPRASERT, Sumitra; LAOHAVINIJ, Sudsawat; MAOLEEKOONPAIROJ, Savitree et al.Chot Mai Het Thang Phaet. 2000, Vol 83, Num 6, pp 676-680, issn 0125-2208, 5 p.Article

Kaposi's sarcoma in rheumatic diseasesLOUTHRENOO, Worawit; KASITANON, Nuntana; MAHANUPHAB, Pongsak et al.Seminars in arthritis and rheumatism. 2003, Vol 32, Num 5, pp 326-333, issn 0049-0172, 8 p.Article

A phase II study of docetaxel and carboplatin in thai patients with advanced non-small-cell lung cancerTHONGPRASERT, Sumitra; SOORRARITCHINGCHAI, Sirikul; CHEWASKULYONG, Busayamas et al.Chot Mai Het Thang Phaet. 2006, Vol 89, Num 2, pp 152-159, issn 0125-2208, 8 p.Article

Phase II Study of Cisplatin Combined to Irinotecan Administered Alternatingly with Docetaxel in Advanced Non-Small Cell Lung CancerCHAROENTUM, Chaiyut; THONGPRASERT, Sumitra; CHEWASAKULYONG, Busayamas et al.Chot Mai Het Thang Phaet. 2007, Vol 90, Num 11, pp 2506-2512, issn 0125-2208, 7 p.Article

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III TrialSCAGLIOTTI, Giorgio V; KRZAKOWSKI, Maciej; PAPAI, Zsolt S et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, issn 0732-183X, 9 p.Article

Erlotinib in previously treated non-small-cell lung cancerSHEPHERD, Frances A; PEREIRA, José Rodrigues; VAN KOOTEN, Maximiliano et al.The New England journal of medicine. 2005, Vol 353, Num 2, pp 123-132, issn 0028-4793, 10 p.Article

Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From AsiaSHUKUI QIN; YUXIAN BAI; JEE HYUN LEE et al.Journal of clinical oncology. 2013, Vol 31, Num 28, pp 3501-3508, issn 0732-183X, 8 p.Article

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non―Small-Cell Lung Cancer in Asia (IPASS)FUKUOKA, Masahiro; WU, Yi-Long; DUFFIELD, Emma L et al.Journal of clinical oncology. 2011, Vol 29, Num 21, pp 2866-2875, issn 0732-183X, 10 p.Article

Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung CancerNATALE, Ronald B; THONGPRASERT, Sumitra; BARLESI, Fabrice et al.Journal of clinical oncology. 2011, Vol 29, Num 8, pp 1059-1066, issn 0732-183X, 8 p.Article

Impact of EGFR Inhibitor in Non―Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-AnalysisCHEE KHOON LEE; BROWN, Chris; JEMELA ANNE OSORIO SANCHEZ et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 9, pp 595-605, issn 0027-8874, 11 p.Article

A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational studyJUN HO YI; THONGPRASERT, Sumitra; LEE, Jeeyun et al.European journal of cancer (1990). 2012, Vol 48, Num 2, pp 196-201, issn 0959-8049, 6 p.Article

Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS studyWU, Yi-Long; FUKUOKA, Masahiro; MOK, Tony S. K et al.Lung cancer. 2013, Vol 81, Num 2, pp 280-287, issn 0169-5002, 8 p.Article

Gefitinib or Carboplatin-Paclitaxel in Pulmonary AdenocarcinomaMOK, Tony S; WU, Yi-Long; NISHIWAKI, Yutaka et al.The New England journal of medicine. 2009, Vol 361, Num 10, pp 947-957, issn 0028-4793, 11 p.Article

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer : results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). CommentaryTHATCHER, Nick; CHANG, Alex; CARROLL, Kevin et al.Lancet (British edition). 2005, Vol 366, Num 9496, pp 1507-1508, issn 0140-6736, 13 p.Article